Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -38.92% is 61% below its 5-year average of -24.22%, near the low end of its 5-year range (-38.92%–-4.88%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.82% below its 12-month average of -37.13%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -38.92%.
RETURN ON INVESTED CAPITAL (ROIC)
-38.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-37.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-30.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-24.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.82%
CURRENT VS 3Y AVG
-26.67%
CURRENT VS 5Y AVG
-60.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-9.20%
vs the sector median at left
Design Therapeutics, Inc.
Market Cap
$747.61M
Return on Invested Capital (ROIC)
-38.92%
TTM Avg
-37.13%
3Y Avg
-30.73%
5Y Avg
-24.22%
Market Cap
$742.70M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$753.02M
Return on Invested Capital (ROIC)
-42.83%
TTM Avg
-51.53%
3Y Avg
-51.53%
5Y Avg
-51.53%
Market Cap
$761.37M
Return on Invested Capital (ROIC)
3.29%
TTM Avg
2.60%
3Y Avg
-15.46%
5Y Avg
-9.88%
Market Cap
$765.30M
Return on Invested Capital (ROIC)
-67.58%
TTM Avg
-58.16%
3Y Avg
-53.29%
5Y Avg
-45.15%
Market Cap
$723.18M
Return on Invested Capital (ROIC)
-36.83%
TTM Avg
-41.75%
3Y Avg
-59.42%
5Y Avg
-51.49%
Market Cap
$721.69M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-136.50%
3Y Avg
-154.74%
5Y Avg
-122.58%
Market Cap
$776.24M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
-22.82%
3Y Avg
-51.67%
5Y Avg
-50.32%
Market Cap
$777.34M
Return on Invested Capital (ROIC)
-23.16%
TTM Avg
-53.28%
3Y Avg
-63.06%
5Y Avg
-59.41%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Design Therapeutics, Inc. (DSGN) | $747.61M | -38.92% | -37.13% | -30.73% | -24.22% |
| Apnimed, Inc. (APMD)vs › | $742.70M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | -42.83% | -51.53% | -51.53% | -51.53% |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | 3.29% | 2.60% | -15.46% | -9.88% |
| Sana Biotechnology, Inc. (SANA)vs › | $765.30M | -67.58% | -58.16% | -53.29% | -45.15% |
| Candel Therapeutics, Inc. (CADL)vs › | $723.18M | -36.83% | -41.75% | -59.42% | -51.49% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $721.69M | N/A | -136.50% | -154.74% | -122.58% |
| Geron Corporation (GERN)vs › | $776.24M | -8.34% | -22.82% | -51.67% | -50.32% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | -23.16% | -53.28% | -63.06% | -59.41% |
| Varex Imaging Corporation (VREX)vs › | $778.01M | 6.30% | -3.00% | 1.90% | 3.29% |
ROIC
-38.9%
ROE
-35.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -38.92% |
| 2026-03-31 | -35.76% |
| 2025-12-31 | -37.28% |
| 2025-09-30 | -38.71% |
| 2025-06-30 | -34.99% |
| 2025-03-31 | -29.84% |
| 2024-12-31 | -25.61% |
| 2024-09-30 | -23.92% |
| 2024-06-30 | -24.08% |
| 2024-03-31 | -26.11% |
| 2023-12-31 | -27.92% |
| 2023-09-30 | -28.68% |
| 2023-06-30 | -27.66% |
| 2023-03-31 | -24.03% |
| 2022-12-31 | -20.46% |
| 2022-09-30 | -17.24% |
| 2022-06-30 | -14.28% |
| 2022-03-31 | -11.66% |
| 2021-12-31 | -9.30% |
| 2021-09-30 | -7.23% |
| 2021-06-30 | -4.88% |
| 2021-03-31 | -3.28% |
| 2020-12-31 | -24.37% |
